Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Piero Fabris"'
Autor:
Marco Montillo, Alessandra Tedeschi, Livio Pagano, Adriano Venditti, Felicetto Ferrara, Piero Fabris, Bruno Martino, Maurizio Musso, Gennaro De Rosa, Giorgina Specchia, Michele Monaco, Giovanni Sparaventi, Antonio Spadea, Angelo Palmas, Wilma Deplano, Annunziata Manna, Lorella Melillo, Eustachio Miraglia, Salvatore Mirto, Franco Mandelli for the Gimema Group
Publikováno v:
British Journal of Haematology. 111:334-337
Autor:
Clara Guarnaccia, Rosangela Invernizzi, Luigi Resegotti, Eugenio Damask, Teodoro Chisesi, Franco Lauria, T. Lamparelli, Giuseppe Rossi, Piero Fabris, Pietro Leoni, Antonio Frassoldati, Guido Pagnucco, Giovanni Capnist, Massimo Federico
Publikováno v:
Leukemia & Lymphoma. 14:457-464
Eighty nine of 104 patients with hairy cell leukemia (HCL), enrolled between 1985 and 1987 in a multicenter prospective study on human lymphoblastoid IFN alpha-n1, were evaluable for long-term follow-up. The induction treatment, 3 MU/mq daily for a m
Autor:
Lucilla Tedeschi, Piero Fabris, Teodoro Chisesi, Mauro Spriano, Vittorio Rizzoli, Giovanni Capnist, Luisa Craviotto, A. Contu, Olmeo N, Michele Vespignani, Eugenio Damasio
Publikováno v:
Acta Oncologica. 33:527-529
In 1990 the Italian Non-Hodgkin's Lymphoma Cooperative Study Group (NHLSG) started a multicenter study on the role of interferon (IFN) in multiple myeloma (MM). The schedule of treatment was based on the assumption that melphalan plus prednisone (MP)
Autor:
Marco Montillo, Alessandra Tedeschi, Livio Pagano, Adriano Venditti, Felicetto Ferrara, Piero Fabris, Bruno Martino, Maurizio Musso, Gennaro De Rosa, Giorgina Specchia, Michele Monaco, Giovanni Sparaventi, Antonio Spadea, Angelo Palmas, Wilma Deplano, Annunziata Manna, Lorella Melillo, Eustachio Miraglia, Salvatore Mirto, Franco Mandelli for the Gimema Group
Elderly patients with untreated acute myeloid leukaemia (AML, n = 47) tested the feasibility of out-patient consolidation therapy and post-consolidation treatment (for patients aged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00753fd40b7b3c709872ea40981eeaa
http://hdl.handle.net/2108/87328
http://hdl.handle.net/2108/87328
Autor:
T. Andrew Lister, Eros Di Bona, Piero Fabris, Tiziano Barbui, Giorgio Lambertenghi-Deliliers, T. Lerede, Renato Bassan, M. Carter, Adolfo Porcellini, Ama Z. S. Rohatiner, Alessandro Rambaldi, Giuseppe Rossi, Enrico Pogliani
Publikováno v:
Drug Resistance in Leukemia and Lymphoma III ISBN: 9781461371809
Translocation t(9;22) or Philadelphia chromosome (Ph)/BCR-ABL rearrangement positive acute lymphoblastic leukemia (Ph/BCR+ ALL) is associated with a very short survival of about one year in most patients.We analyzed long-term outcome of 76 adults wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea6bb695e1b6a792d591be5c09f4ecf2
https://doi.org/10.1007/978-1-4615-4811-9_53
https://doi.org/10.1007/978-1-4615-4811-9_53